These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 35668248)

  • 1. A Framework for Integrating Continuous Glucose Monitor-Derived Metrics into Economic Evaluations in Type 1 Diabetes.
    Benedict Á; Hankosky ER; Marczell K; Chen J; Klein DJ; Caro JJ; Bae JP; Benneyworth BD
    Pharmacoeconomics; 2022 Aug; 40(8):743-750. PubMed ID: 35668248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrated sensor-augmented pump therapy systems [the MiniMed® Paradigm™ Veo system and the Vibe™ and G4® PLATINUM CGM (continuous glucose monitoring) system] for managing blood glucose levels in type 1 diabetes: a systematic review and economic evaluation.
    Riemsma R; Corro Ramos I; Birnie R; Büyükkaramikli N; Armstrong N; Ryder S; Duffy S; Worthy G; Al M; Severens J; Kleijnen J
    Health Technol Assess; 2016 Feb; 20(17):v-xxxi, 1-251. PubMed ID: 26933827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complications of Diabetes and Metrics of Glycemic Management Derived From Continuous Glucose Monitoring.
    Yapanis M; James S; Craig ME; O'Neal D; Ekinci EI
    J Clin Endocrinol Metab; 2022 May; 107(6):e2221-e2236. PubMed ID: 35094087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beyond HbA
    Brown SA; Basu A; Kovatchev BP
    Diabet Med; 2019 Jun; 36(6):679-687. PubMed ID: 30848545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glycated albumin and continuous glucose monitoring metrics across pregnancy in women with pre-gestational diabetes.
    Toft JH; Dalen I; Skadberg Ø; Gøransson LG; Økland I; Bleskestad IH
    Endocrinol Diabetes Metab; 2022 Nov; 5(6):e376. PubMed ID: 36121204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beyond HbA1c.
    Bloomgarden Z
    J Diabetes; 2017 Dec; 9(12):1052-1053. PubMed ID: 28792665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of novel flash glucose monitoring system on glycaemic control in adult patients with type 1 diabetes mellitus: protocol of a multicentre randomised controlled trial.
    Zhou Y; Deng H; Liu H; Yang D; Xu W; Yao B; Yan J; Weng J
    BMJ Open; 2020 Dec; 10(12):e039400. PubMed ID: 33277281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effectiveness of continuous subcutaneous insulin pumps with continuous glucose monitoring in outpatient adolescents with type 1 diabetes: A systematic review.
    Matsuda E; Brennan P
    JBI Libr Syst Rev; 2012; 10(42 Suppl):1-10. PubMed ID: 27820140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Associations between continuous glucose monitoring-derived metrics and HbA1c in patients with type 2 diabetes mellitus.
    Kurozumi A; Okada Y; Mita T; Wakasugi S; Katakami N; Yoshii H; Kanda K; Nishida K; Mine S; Tanaka Y; Gosho M; Shimomura I; Watada H
    Diabetes Res Clin Pract; 2022 Apr; 186():109836. PubMed ID: 35314256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomised controlled trial to compare minimally invasive glucose monitoring devices with conventional monitoring in the management of insulin-treated diabetes mellitus (MITRE).
    Newman SP; Cooke D; Casbard A; Walker S; Meredith S; Nunn A; Steed L; Manca A; Sculpher M; Barnard M; Kerr D; Weaver J; Ahlquist J; Hurel SJ
    Health Technol Assess; 2009 May; 13(28):iii-iv, ix-xi, 1-194. PubMed ID: 19476724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypo-METRICS: Hypoglycaemia-MEasurement, ThResholds and ImpaCtS-A multi-country clinical study to define the optimal threshold and duration of sensor-detected hypoglycaemia that impact the experience of hypoglycaemia, quality of life and health economic outcomes: The study protocol.
    Divilly P; Zaremba N; Mahmoudi Z; Søholm U; Pollard DJ; Broadley M; Abbink EJ; de Galan B; Pedersen-Bjergaard U; Renard E; Evans M; Speight J; Brennan A; McCrimmon RJ; Müllenborn M; Heller S; Seibold A; Mader JK; Amiel SA; Pouwer F; Choudhary P;
    Diabet Med; 2022 Sep; 39(9):e14892. PubMed ID: 35633291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Continuous Glucose Monitoring for the Internist.
    Lee GS; Lupsa BC
    Med Clin North Am; 2021 Nov; 105(6):967-982. PubMed ID: 34688421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness analysis of real-time continuous monitoring glucose compared to self-monitoring of blood glucose for diabetes mellitus in Spain.
    García-Lorenzo B; Rivero-Santana A; Vallejo-Torres L; Castilla-Rodríguez I; García-Pérez S; García-Pérez L; Perestelo-Pérez L
    J Eval Clin Pract; 2018 Aug; 24(4):772-781. PubMed ID: 29971893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Application of medium-term metrics for assessing glucose homoeostasis: Usefulness, strengths and weaknesses.
    Monnier L; Colette C; Owens D
    Diabetes Metab; 2021 Mar; 47(2):101173. PubMed ID: 32561428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Continuous Glucose Monitoring on Hypoglycemia in Older Adults With Type 1 Diabetes: A Randomized Clinical Trial.
    Pratley RE; Kanapka LG; Rickels MR; Ahmann A; Aleppo G; Beck R; Bhargava A; Bode BW; Carlson A; Chaytor NS; Fox DS; Goland R; Hirsch IB; Kruger D; Kudva YC; Levy C; McGill JB; Peters A; Philipson L; Philis-Tsimikas A; Pop-Busui R; Shah VN; Thompson M; Vendrame F; Verdejo A; Weinstock RS; Young L; Miller KM;
    JAMA; 2020 Jun; 323(23):2397-2406. PubMed ID: 32543682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Continuous Glucose Monitoring on Glycemic Control in Adolescents and Young Adults With Type 1 Diabetes: A Randomized Clinical Trial.
    Laffel LM; Kanapka LG; Beck RW; Bergamo K; Clements MA; Criego A; DeSalvo DJ; Goland R; Hood K; Liljenquist D; Messer LH; Monzavi R; Mouse TJ; Prahalad P; Sherr J; Simmons JH; Wadwa RP; Weinstock RS; Willi SM; Miller KM; ;
    JAMA; 2020 Jun; 323(23):2388-2396. PubMed ID: 32543683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Relationships Between Time in Range, Hyperglycemia Metrics, and HbA1c.
    Beck RW; Bergenstal RM; Cheng P; Kollman C; Carlson AL; Johnson ML; Rodbard D
    J Diabetes Sci Technol; 2019 Jul; 13(4):614-626. PubMed ID: 30636519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monitoring of paediatric type 1 diabetes.
    Marks BE; Wolfsdorf JI
    Curr Opin Pediatr; 2022 Aug; 34(4):391-399. PubMed ID: 35836398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationships between HbA1c and continuous glucose monitoring metrics of glycaemic control and glucose variability in a large cohort of children and adolescents with type 1 diabetes.
    Piona C; Marigliano M; Mozzillo E; Rosanio F; Zanfardino A; Iafusco D; Maltoni G; Zucchini S; Piccinno E; Delvecchio M; Maffeis C
    Diabetes Res Clin Pract; 2021 Jul; 177():108933. PubMed ID: 34216681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psychological interventions to improve self-management of type 1 and type 2 diabetes: a systematic review.
    Winkley K; Upsher R; Stahl D; Pollard D; Kasera A; Brennan A; Heller S; Ismail K
    Health Technol Assess; 2020 Jun; 24(28):1-232. PubMed ID: 32568666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.